soul trial oral semaglutide cardiovascular outcomes trial Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 Oral Semaglutide in High-Risk Type

Semaglutide typically begins reducing appetite within three to five days of your first injection, though noticeable weight loss usually appears within two to four weeks as your body adjusts to the medication

This webinar with obesity medicine physician Jonathan Bonnet, MD, MPH, a GLP-1RA expert, will answer all your questions about the medications, how they work, their benefits, their side effects, and how they can be combined with lifestyle changes to optimize your weight loss and body composition.

Purchase does not guarantee dispensing of medication

GLP-1 medications for weight loss, including semaglutide and tirzepatide, are transforming obesity care

Part 1/3 of the GLP-1 Support System